Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Saleem Ansari MRCP (UK), BSc, MBChB

Saleem Ansari MRCP (UK), BSc, MBChB

Chain-Florey Clinical Research Fellow, Medical Research Council Laboratory of Medicine Science, Imperial College London, London, United Kingdom

Dr. Saleem Ansari is a Clinical Research Fellow at the Medical Research Council Laboratory of Medical Sciences at the Hammersmith Campus of Imperial College London.

He graduated with MBChB(Hons) from the University of Leicester in 2015. Prior to this he gained a first class BSc(Hons) in Sports & Exercise Science at the University of Bath. Following on from medical school, he undertook house and senior house officer training in Wales before moving to London where he spent 6-months at King’s College Hospital NHS Foundation Trust before taking up his speciality training in Metabolic Medicine and Chemical Pathology at Imperial College Healthcare NHS Trust. Since joining Imperial, he has worked within a team led by Professor Tricia Tan. He has conducted research on pregnant women that have undergone bariatric surgery using continuous glucose monitoring, a phase 1 randomised controlled trial (RCT) investigating the metabolic effects of a gut hormone infusion in people with obesity and a RCT in patients with obesity and type 2 diabetes undergoing a modified version of Roux-en-Y gastric bypass surgery (the LONG LIMB study).  He is currently undertaking his PhD at Imperial College London investigating ways to optimise glucagon receptor agonism for metabolic-dysfunction associated steatotic liver disease, obesity and type 2 diabetes.

Disclosures

Dr. Ansari has no relevant disclosures.